Company Filing History:
Years Active: 1989
Title: The Innovations of Deborah A. Jorn
Introduction
Deborah A. Jorn is a notable inventor based in Metuchen, NJ (US). She has made significant contributions to the field of bacterial vaccines through her innovative research and development. With a focus on covalently-modified neutral bacterial polysaccharides, her work has implications for improving vaccine efficacy.
Latest Patents
Deborah A. Jorn holds a patent for "Covalently-modified neutral bacterial polysaccharides." This patent details stable covalent conjugates of such polysaccharides linked by a bigeneric spacer, with immunogenic bacterial membrane or other proteins. These conjugates are useful components of bacterial vaccines, and the patent also outlines methods for preparing these polysaccharides and conjugates.
Career Highlights
Deborah is currently employed at Merck & Company, Inc., a leading global healthcare company. Her role involves extensive research in vaccine development, where she applies her expertise in polysaccharide chemistry to create innovative solutions for public health.
Collaborations
Throughout her career, Deborah has collaborated with esteemed colleagues such as Stephen Marburg and Richard L. Tolman. These partnerships have enhanced her research and contributed to the advancement of vaccine technology.
Conclusion
Deborah A. Jorn's work exemplifies the intersection of innovation and public health. Her contributions to bacterial vaccine development through her patented inventions are invaluable in the fight against infectious diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.